Klay Jones is a strategic leader with 19 years of experience in clinical and commercial biotech, currently serving as the Director of Portfolio Management at Pfizer. Having previously built clinical supply, supply chain, and QC departments from scratch at multiple startups, Klay is passionate about leveraging data to implement lean strategies that expedite therapy delivery. Klay's extensive background includes roles at notable companies such as Vir Biotechnology and Juno Therapeutics, where they contributed to the advancement of innovative therapies and operational efficiency. Klay holds a B.S. in Biochemistry and Chemistry from the University of Washington.
This person is not in any teams
This person is not in any offices